HCVD2MAG-67K MILLIPLEX MAP Human Cardiovascular Disease (CVD) Magnetic Bead Panel 2 - Cardiovascular Disease Multiplex Assay

HCVD2MAG-67K
Design And Price Your Kit

Overview

Replacement Information

Key Specifications Table

Analytes AvailableSpecies ReactivityKey ApplicationsDetection Methods
ADAMTS13, D-Dimer, GDF-15, Myoglobin, sICAM-1, MPO, P-selectin, Lipocalin-2/NGAL, sVCAM-1, SAA H Mplex Luminex xMAP
Description
Catalogue NumberHCVD2MAG-67K
Trade Name
  • MILLIPLEX
DescriptionMILLIPLEX MAP Human Cardiovascular Disease (CVD) Magnetic Bead Panel 2 - Cardiovascular Disease Multiplex Assay
OverviewThe MILLIPLEX MAP Human CVD Magnetic Bead Panel 2 is the most versatile system available for Cardiovascular research.

• MILLIPLEX MAP offers you the ability to:
o Select a 10-plex or
o Choose any combination of analytes from our panel of 10 analytes to design a custom kit that better meets your needs.
• A convenient “all-in-one” box format gives you the assurance that you will have all the necessary reagents you need to run your assay.

The MILLIPLEX MAP Human CVD Magnetic Bead Panel 2 is to be used for the simultaneous quantification from the following Adamts13, D-dimer, GDF-15, Myoglobin, sICAM-1, MPO, P-selectin, Lipocalin-2/NGAL, sVCAM-1 and SAA.
References
Product Information
Detection methodLuminex xMAP
ConfigurationDesign your multiplex kit by choosing available analytes within this panel.
Precision, %
  • Intra-assay: < 15%
  • Inter-assay: < 20%
Panel TypeMAGNETIC Cardiovascular
Applications
ApplicationThe analytes available for this multiplex kit are: ADAMTS13, D-Dimer, GDF-15, Myoglobin, sICAM-1, MPO, P-selectin, Lipocalin-2/NGAL, sVCAM-1, SAA.
Key Applications
  • Multiplexing
Application NotesSerum and plasma samples require a 1:100 dilution.
D-Dimer cannot be measured in plasma samples.
Biological Information
Species Reactivity
  • Human
Analytes Available
  • ADAMTS13
  • D-Dimer
  • GDF-15
  • Myoglobin
  • sICAM-1
  • MPO
  • P-selectin
  • Lipocalin-2/NGAL
  • sVCAM-1
  • SAA
Cross ReactivityThere was no or negligible cross-reactivity between the antibodies for an analyte and any of the other analytes in this panel.
Accuracy
  • ADAMTS13 & Lipocalcin-2/NGAL 94%
  • D-Dimer & sICAM-1 83%
  • GDF-15 98%
  • Myoglobin 88%
  • MPO & SAA 96%
  • P-selectin 90%
  • sVCAM-1 95%
Physicochemical Information
Sensitivity
  • See kit protocol for individual analytes sensitive’s.
Linearity of DilutionContact technical support for linearity of dilution.
Standard Curve Range
  • GDF-15: 0.0005-2.5 ng/mL
  • Lipocalcin-2/NGAL: 0.012-50 ng/mL
  • Myoglobin & MPO: 0.024-100 ng/mL
  • sVCAM-1: 0.122-500 ng/mL
  • sICAM-1: 0.085-350 ng/mL
  • D-dimer, SAA & P-selectin: 0.244-1,000 ng/mL
  • ADAMTS 13: 1.221-5,000 ng/mL
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Packaging Information
Material Size96-well plate
Transport Information
Supplemental Information
Specifications

Documentation

Protocols

Title
Protocol: Human Cardiovascular Disease (CVD) Panel 2 Magnetic Bead Kit

MILLIPLEX MAP Human Cardiovascular Disease (CVD) Magnetic Bead Panel 2 - Cardiovascular Disease Multiplex Assay SDS

Title

Safety Data Sheet (SDS) 

References

Reference overviewPub Med ID
Systemic treatment and narrowband ultraviolet B differentially affect cardiovascular risk markers in psoriasis.
Sigurdardottir, G; Ekman, AK; Ståhle, M; Bivik, C; Enerbäck, C
Journal of the American Academy of Dermatology  70  1067-75  2014

Show Abstract
24656729 24656729
Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis.
Tasset, I; Bahamonde, C; Agüera, E; Conde, C; Cruz, AH; Pérez-Herrera, A; Gascón, F; Giraldo, AI; Ruiz, MC; Lillo, R; Sánchez-López, F; Túnez, I
Pharmacological reports : PR  65  624-31  2013

Show Abstract
23950585 23950585

Brochure

Title
A closer look at immunoassay platforms. Beyond fit for purpse. Bring your biomarkers to life with EMD Millipore Immunoassay Platform Solutions (SigmaMillipore)
Protein Detection Platform and Services Brochure
The Power of Biomarker Analysis

Technical Info

Title
96 well Template 2 Up
96 well Template Single
HCVD2MAG-67K xPonent Protocol Template Version Magpix
HCVD2MAG-67K xPonent Standard Template Version Magpix
Measurement of cardiovascular disease biomarkers in human clinical samples using magnetic bead-based MILLIPLEX® MAP multiplex panels
Quality Control Ranges: Milliplex Human Cardiovascular Disease Magnetic Bead Panel 2

Data Sheet

Title
Full Service Custom-built Assays